Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07792421 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pain Phenotype and Response to Corticosteroid Injection in Patients With Subacromial Pain Syndrome (SAPS)

Study acronym: NAP SAPS CSI
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Vejle Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified
    • Start date pushed from Sep 15, 2026 to Oct 19, 2026
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: 8 to 11
  2. Eligibility criteria revisedv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Vejle Hospital
29 trials monitored
See 2 trials at risk
The goal of this prospective cohort study is to investigate whether pain phenotype is associated with subsequent change in pain intensity after corticosteroid injection given as part of routine care in patients diagnosed with SAPS. The main question it aims to answer is: Does change in shoulder pain from baseline to 4 weeks after corticosteroid injection differ between patients classified as having a nociplastic pain phenotype and those classified as having a non-nociplastic pain phenotype?
Trial Details
NCT Number NCT07792421
Lead Sponsor Vejle Hospital
Conditions
(from sponsor)		 Subacromial Pain Syndrome, Rotator Cuff Related Shoulder Pain, Shoulder Pain, Shoulder Impingement Syndrome, SAPS
Related terms Chronic Pain, Musculoskeletal Pain, Nociplastic Pain, Shoulder Impingement Syndrome, Shoulder Pain
Enrollment 134 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov